Company Filing History:
Years Active: 2005-2013
Title: MinKyung Yi: Innovator in Hepatitis C Research
Introduction
MinKyung Yi is a prominent inventor based in Galveston, TX (US). She has made significant contributions to the field of hepatitis C research, holding a total of 3 patents. Her work focuses on developing methods and tools to combat this challenging virus.
Latest Patents
MinKyung Yi's latest patents include groundbreaking inventions related to replication competent hepatitis C viruses. One of her patents provides a replication competent hepatitis C virus that includes a heterologous polynucleotide. This invention encompasses methods for modifying a hepatitis C virus polynucleotide, selecting a replication competent hepatitis C virus polynucleotide, detecting a replication competent hepatitis C virus polynucleotide, and identifying compounds that inhibit the replication of a hepatitis C virus polynucleotide. Another patent presents replication competent polynucleotides that include a coding sequence encoding a hepatitis C virus polyprotein with adaptive mutations. This invention also includes methods for making replication competent polynucleotides, identifying compounds that inhibit replication, selecting replication competent polynucleotides, and detecting replication competent polynucleotides.
Career Highlights
MinKyung Yi is affiliated with the University of Texas System, where she continues her research and innovation in the field of virology. Her work has been instrumental in advancing the understanding of hepatitis C and developing potential therapeutic strategies.
Collaborations
MinKyung Yi collaborates with notable researchers in her field, including Stanley M. Lemon. Their joint efforts contribute to the ongoing research and development of effective treatments for hepatitis C.
Conclusion
MinKyung Yi's innovative work in hepatitis C research highlights her dedication to advancing medical science. Her patents and collaborations reflect her significant impact on the field, paving the way for future breakthroughs in combating this virus.